A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Clinical trial NCT00002239 · COMPLETED
Trial details
- NCT number
- NCT00002239
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-05-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.